# Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia

> **NCT03669484** · PHASE3 · COMPLETED · sponsor: **R-Pharm** · enrollment: 150 (actual)

## Conditions studied

- General Anaesthesia

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol
- **DRUG:** Fentanyl
- **DRUG:** Rocuronium bromide

## Key facts

- **NCT ID:** NCT03669484
- **Lead sponsor:** R-Pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-22
- **Primary completion:** 2018-05-15
- **Final completion:** 2018-05-24
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03669484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03669484, "Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03669484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*